1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP

Arbutus Biopharma Corp

XNAS: ABUS

Download real time

3.20 -0.08 (-2.44%)

32.20% Fall from 52W High

320.3K XNAS Volume

XNAS 18 Mar, 2025 3:10 PM (EDT)

Watchlist

Portfolio

Share
8S
16W
3O
1T
606.4

Market Cap

Below industry Median
-7.9

PE TTM

Negative PE TTM
4.8

PEG TTM

PEG TTM is much higher than 1
5.7

Price to Book

High in industry
0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Arbutus Biopharma Corp is on 21 Mar 2025 for the purpose of Arbutus Biopharma Corp Annual Report for 2024 See details

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 4 analysts

Arbutus Biopharma Corp has a share price target of US$ 5, revenue growth forecast of -67.5%, and profit growth estimate of 4.3% for FY24, based on top 4 analyst calls.

Forecaster Screeners